Objective: To evaluate preoperative levels of CA-125 for the prediction of advanced stages of uterine cancer.
Study Design: Retrospective chart review of 141 women with endometrial cancer who were treated by a single gynecologic oncologist at a community teaching hospital in North Carolina between November 1994 and September 2002.
Results: Ninety-three of 106 patients (87.